SCHEMBL12931702

SCHEMBL12931702

CN1CCCC1CCNC(=O)CSc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 4/20 0.53
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ GLS O94925 1/20 0.48
▸ PLD1 Q13393 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ CHRNB2 P17787 1/20 0.45
▸ CHRNA5 P30532 1/20 0.45
▸ CHRNA7 P36544 1/20 0.45
▸ CHRNA4 P43681 1/20 0.45
▸ CHRM3 P20309 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ OPRL1 P41146 1/20 0.44
▸ APP P05067 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13118285 0.80 ACKR3 (0.61) ACKR3CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL7061296 0.76 HTR6 (0.49) NPC1RAB9ACHRNB2CHRNA5CHRNA7
SCHEMBL12961783 0.76 HSD17B10 (0.60) ACKR3NPC1RAB9AKMT2APLD1
SCHEMBL8162955 0.76 ACKR3 (0.63) ACKR3NPC1RAB9ACHRNB2CHRNA5
SCHEMBL12156865 0.75 ACKR3 (0.52) ACKR3KMT2AGLSALDH1A1
SCHEMBL6395379 0.74 ACKR3 (0.51) ACKR3GLSALDH1A1CHRNB2CHRNA5
SCHEMBL13162038 0.74 ACKR3 (0.55) ACKR3NPC1RAB9A
SCHEMBL14817985 0.73 ACKR3 (0.57) ACKR3NPC1RAB9AGLSCHRM3
SCHEMBL3642169 0.73 ACKR3 (0.54) ACKR3CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL27257877 0.72 ACKR3 (0.56) ACKR3GLSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735445-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2014-05-27 — — US disclosed
US-8735445-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2014-05-27 — — US disclosed
EP-1594438-B1 Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or hair OREAL (FR) 2013-07-17 — — EP disclosed
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES L'OREAL (FR) 2011-01-20 — — US disclosed
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES L'OREAL (FR) 2011-01-20 — — US disclosed
US-7705041-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2010-04-27 — — US disclosed
US-7705041-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2010-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES COX15, HPGD, TYR ACKR3 3219/4885NPC1 4861/4885RAB9A 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback